Patents by Inventor Mattias Algotsson
Mattias Algotsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220258130Abstract: The present invention relates to a novel chromatography media, more closely a novel IMAC (Immobilized Metal Affinity Chromatography) media. The novel chromatography media comprises a pentaligand and provides high dynamic binding capacity as well as high purity of the sample proteins purified on the media of the invention.Type: ApplicationFiled: May 3, 2022Publication date: August 18, 2022Inventors: Ann Catharina Bergh, Mattias Algotsson, Tania Ahmad, Therese Graner
-
Patent number: 11014069Abstract: The present invention relates to a method to improve chromatography beads. More closely, the invention relates to a novel method for production of dextran-containing porous media and chromatography media produced with this method. In the method, the chromatography media is subjected to dextranase-treatment leading to improved pressure-flow properties of the media.Type: GrantFiled: October 28, 2016Date of Patent: May 25, 2021Assignee: Cytiva BioProcess R&D ABInventors: Nils Norrman, Mattias Algotsson, Stefan D. Eriksson
-
Patent number: 10662261Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.Type: GrantFiled: March 27, 2018Date of Patent: May 26, 2020Assignee: GE Healthcare BioProcess R&D ABInventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
-
Publication number: 20200023338Abstract: The present invention relates to a novel chromatography media, more closely a novel IMAC (Immobilized Metal Affinity Chromatography) media. The novel chromatography media comprises a pentaligand and provides high dynamic binding capacity as well as high purity of the sample proteins purified on the media of the invention.Type: ApplicationFiled: September 27, 2017Publication date: January 23, 2020Applicant: GE Healthcare BioProcess R&D ABInventors: Ann Catharina Bergh, Tania Ahmad, Mattias Algotsson, Therese Graner
-
Patent number: 10371608Abstract: The invention discloses a cellulose or glass fiber paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.Type: GrantFiled: October 29, 2012Date of Patent: August 6, 2019Assignee: GE Healthcare Bio-Sciences ABInventors: Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
-
Publication number: 20180304231Abstract: The present invention relates to a method to improve chromatography beads. More closely, the invention relates to a novel method for production of dextran-containing porous media and chromatography media produced with this method. In the method, the chromatography media is subjected to dextranase-treatment leading to improved pressure-flow properties of the media.Type: ApplicationFiled: October 28, 2016Publication date: October 25, 2018Applicant: GE Healthcare Bio-Sciences ABInventors: Nils Norrman, Mattias Algotsson, Stefan D. Eriksson
-
Publication number: 20180223003Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.Type: ApplicationFiled: March 27, 2018Publication date: August 9, 2018Inventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
-
Patent number: 9989446Abstract: The invention discloses a sample preservation method which comprises the following steps: a) providing a paper substrate comprising ligands, where the ligands comprise charged groups, b) applying a sample comprising at least one analyte and at least one contaminant on the paper substrate, c) drying the sample on the paper substrate and, d) extracting at least part of the paper substrate to provide a solution of the analyte.Type: GrantFiled: February 27, 2012Date of Patent: June 5, 2018Assignee: GE HEALTHCARE UK LIMITEDInventors: Philip Robert Mallender, Douglas Mark Green, Sarah Janet Clegg, Barry Edmund Johnson, Jimmy Hedin Dahlstrom, Mattias Algotsson, Ronnie Palmgren
-
Patent number: 9944722Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.Type: GrantFiled: May 30, 2011Date of Patent: April 17, 2018Assignee: GE Healthcare Bioprocess R&D ABInventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
-
Publication number: 20140302521Abstract: The invention discloses a cellulose or glass fibre paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.Type: ApplicationFiled: October 29, 2012Publication date: October 9, 2014Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
-
Publication number: 20130330751Abstract: The invention discloses a sample preservation method which comprises the following steps: a) providing a paper substrate comprising ligands, where the ligands comprise charged groups, b) applying a sample comprising at least one analyte and at least one contaminant on the paper substrate, c) drying the sample on the paper substrate and, d) extracting at least part of the paper substrate to provide a solution of the analyte.Type: ApplicationFiled: February 27, 2012Publication date: December 12, 2013Applicant: GE HEALTHCARE UK LIMITEDInventors: Philip Robert Mallender, Douglas Mark Green, Sarah Janet Clegg, Barry Edmund Johnson, Jimmy Hedin Dahlstrom, Mattias Algotsson, Ronnie Palmgren
-
Publication number: 20130072638Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.Type: ApplicationFiled: May 30, 2011Publication date: March 21, 2013Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
-
Publication number: 20110039336Abstract: The present invention relates to a product for cell culture. In particular, the invention relates to a cell growth surface having a coating comprising an animal protein free coating. The coating is derived from an enzymatic hydrolysate of a plant protein, preferably soy peptone. The cell culture product is preferably a microcarrier intended for culture of any anchorage-dependent cells.Type: ApplicationFiled: April 24, 2009Publication date: February 17, 2011Inventors: Mattias Algotsson, Asa Bjurling
-
Publication number: 20100136647Abstract: The present invention relates to the field of adherent cell culture. More closely, the invention relates to a method for production of a cell attachment and culture surface, such as a microcarrier, comprising a guanidino-containing ligand, wherein the ligand is coupled via reaction involving a primary amine to the surface which is activated by activation groups such that the final molar ratio of grafted ligand and ungrafted activation groups is above 1.5. Preferably, the ligand density is above 0.5 mmol/g cell culture surface and the remaining activation groups after coupling is less than 0.6 mmol/g cell culture surface. The cell culture surface may be used for various purposes, primarily cell cultivation and virus production.Type: ApplicationFiled: November 23, 2009Publication date: June 3, 2010Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Mattias Algotsson, Hans Berg, Asa Bjurling, Christian Kaisermayer, Bjorn Noren, Nicholas Thevenin, James Van Alstine
-
Publication number: 20080199959Abstract: The present invention relates to a method for cell culture, more precisely small scale cell culture. In the present invention a screening tool is used which comprises particulate matter or microcarriers, such as beads, attached to a solid support, such as a microtiter plate, for the cultivation of cells on said microcarriers. The microcarriers are preferably cultivation beads, such as CYTODEX™. According to the invention, this small scale format for cell cultivation may be used for any testing involving cells, for example testing of optimal growth conditions for a specific type of cell, such as stem cells. Another use is cell expansion.Type: ApplicationFiled: June 19, 2006Publication date: August 21, 2008Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Mattias Algotsson, Gunnar Glad, Nicolas Thevenin
-
Patent number: 7294743Abstract: The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.Type: GrantFiled: October 18, 2004Date of Patent: November 13, 2007Assignee: GE Healthcare Bio-Sciences ABInventors: Mattias Algotsson, Philippe Busson, Nicolas Thevenin
-
Publication number: 20070106090Abstract: The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase. In a preferred embodiment the acryl amide derivative is an immobiline, preferably acrylamido agmatine. The preferred use of the immobilines is for production of 2D gels.Type: ApplicationFiled: October 18, 2004Publication date: May 10, 2007Inventors: Mattias Algotsson, Philippe Busson, Nicolas Thevenin
-
Patent number: 7060776Abstract: The invention relates to an acrylic monomer defined by formula (I): wherein R1, R2 and R3 are H or CH3; R4 and R5 are H or OH; R6 and R7 are H or OH; R8 is H or CH3; m is 2–4; and n and p are 0 or 1. The invention also relates to a polymer comprised of repeated such monomer units as well as a separation matrix prepared thereof.Type: GrantFiled: December 17, 2002Date of Patent: June 13, 2006Assignee: GE Healthcare Bio-Sciences ABInventors: Mattias Algotsson, Bengt Bjellqvist, Ronnie Palmgren
-
Publication number: 20050113539Abstract: The invention relates to an acrylic monomer defined by formula (1): wherein R1, R2 and R3 are H or CH3; R4 and R5 are H or OH; R6 and R7 are H or OH; R8 is H or CH3; m is 2-4; and n and p are 0 or 1. The invention also relates to a polymer comprised of repeated such monomer units as well as a separation matrix prepared thereof.Type: ApplicationFiled: December 17, 2002Publication date: May 26, 2005Inventors: Mattias Algotsson, Bengt Bjellqvist, Ronnie Palmgren